HIGHLIGHTS: Emma Walmsley - CEO of GSK
We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/gsk-ceo-drug-discovery-ai-in-pharma-and-changing/id1614211565?i=1000701828482&l=nb How is the pharmaceutical industry evolving to meet the world’s biggest health…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from In Good Company with Nicolai Tangen
See all episodes →
43%Venki Ramakrishnan: The Science and Hype of Living Longer
41%Eliot Higgins: How Bellingcat Hunts Down the Truth
39%Horizon Robotics CEO: Car Chips, Mind-Off Driving and China's Speed
Similar episodes from other shows
More like In Good Company with Nicolai Tangen →
Leadership in the age of AI | Paul Hudson and Lindsay Levin
Corner Office Conversation With Umang Vohra, MD and Global CEO, Cipla
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
Daphne Koller on drug discovery and AI
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.